Trilantic Europe Founding Partners have worked together on average for over 20 years with an average tenure for all Partners and Principals of over 10 years.
Key pan-European languages spoken by our Investment Professionals
All investment professionals are fully fluent in at least two of our key languages with over 40% fully proficient in three or more languages
Years with the firm of our Investment Professionals
In addition to the investment team and finance professionals, Trilantic Europe’s network is supplemented by 12 Operating Partners and Senior Advisors as well as the Advisory Council, which has been active and chaired by Lord Baker since 2004, bringing together a group of 18 prominent Council members. Trilantic Europe draws upon their collective experience and relationships to help source investments, assist with investment evaluation and due diligence, as well as to provide post acquisition support.
Dr. Ulrich Wandschneider is the chairman of the Advisory Board of Trilantic Europe´s portfolio companies Oberberg, SmileEyes, and Argentum. He has gained 15 years experience as CEO and Chairman of the supervisory boards of Asklepios Kliniken GmbH & Co.KGaA, Hamburg, the second largest hospital group in Germany, and MediClin AG, Offenburg. Before his industry managerial positions, he worked for 17 years for the consulting firms Arthur Andersen and Deloitte Consulting - the last seven years as Partner of 'Lifescience & Healthcare'. He has consulting and management experience in Healthcare for more than 25 years. Additionally, he is a Trustee of the Hanns-Martin-Schleyer-Stiftung, Berlin, and is experienced in further supervisory boards of family-owned and publicly traded companies including serving as a member of the supervisory board of German biotechnology company, BioNTech SE, Mainz, since 2018. Dr. Wandschneider holds a Diploma and a Doctor´s degree in Business Administration.